Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


1 Am J Epidemiol
1 Ann Surg
9 Anticancer Res
3 BMC Cancer
1 BMC Gastroenterol
1 Cancer
1 Cancer Lett
1 Clin Cancer Res
1 Gastrointest Endosc
1 Gut
1 Int J Colorectal Dis
1 J Clin Oncol
2 J Surg Oncol
1 Oncology
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Epidemiol

  1. WASSERTHEIL-SMOLLER S, McGinn AP, Martin L, Rodriguez BL, et al
    The Associations of Atrial Fibrillation With the Risks of Incident Invasive Breast and Colorectal Cancer.
    Am J Epidemiol. 2017 Feb 8:1-13. doi: 10.1093.
    PubMed     Text format    

    Ann Surg

  2. WONG GY, Kumar R, Beeke C, Ullah S, et al
    Survival Outcomes for Patients With Indeterminate 18FDG-PET Scan for Extrahepatic Disease Before Liver Resection for Metastatic Colorectal Cancer: A Retrospective Cohort Study Using a Prospectively Maintained Database to Analyze Survival Outcomes for
    Ann Surg. 2017 Feb 6. doi: 10.1097/SLA.0000000000002170.
    PubMed     Text format     Abstract available

    Anticancer Res

  3. DE FELICE F, Musio D, Benevento I, Magnante A, et al
    Influence of Organ Invasion in Clinical Outcomes for Locally Advanced Rectal Cancer.
    Anticancer Res. 2016;36:5443-5447.
    PubMed     Text format     Abstract available

  4. RUBIO CA, Schmidt PT
    Gut-associated Lymphoid Tissue (GALT) Carcinoma or Dome Carcinoma?
    Anticancer Res. 2016;36:5385-5387.
    PubMed     Text format     Abstract available

  5. NONAKA T, Fukuda A, Maekawa K, Nagayoshi S, et al
    Clinical and Oncological Outcomes of Laparoscopic Versus Open Surgery for Advanced Rectal Cancer.
    Anticancer Res. 2016;36:5419-5424.
    PubMed     Text format     Abstract available

  6. BISCANIN A, Ljubicic N, Boban M, Balicevic D, et al
    CX43 Expression in Colonic Adenomas and Surrounding Mucosa Is a Marker of Malignant Potential.
    Anticancer Res. 2016;36:5437-5442.
    PubMed     Text format     Abstract available

  7. CHUNG SS, Adekoya D, Enenmoh I, Clarke O, et al
    Salinomycin Abolished STAT3 and STAT1 Interactions and Reduced Telomerase Activity in Colorectal Cancer Cells.
    Anticancer Res. 2017;37:445-453.
    PubMed     Text format     Abstract available

  8. IWATA N, Ishikawa T, Okazaki S, Mogushi K, et al
    Clinical Significance of Methylation and Reduced Expression of the Quaking Gene in Colorectal Cancer.
    Anticancer Res. 2017;37:489-498.
    PubMed     Text format     Abstract available

  9. HAGLAND HR, Lea D, Watson MM, Soreide K, et al
    Correlation of Blood T-Cells to Intratumoural Density and Location of CD3+ and CD8+ T-Cells in Colorectal Cancer.
    Anticancer Res. 2017;37:675-683.
    PubMed     Text format     Abstract available

  10. KANEKO M, Ishihara S, Murono K, Sasaki K, et al
    Carbohydrate Antigen 19-9 Predicts Synchronous Peritoneal Carcinomatosis in Patients with Colorectal Cancer.
    Anticancer Res. 2017;37:865-870.
    PubMed     Text format     Abstract available

  11. HA GS, Kim YW, Choi EH, Kim IY, et al
    Factors Associated with the Lack of Adjuvant Chemotherapy Following Curative Surgery for Stage II and III Colon Cancer: A Korean National Cohort Study.
    Anticancer Res. 2017;37:915-922.
    PubMed     Text format     Abstract available

    BMC Cancer

  12. CAREY M, Sanson-Fisher R, Macrae F, Cameron E, et al
    Improving adherence to colorectal cancer surveillance guidelines: results of a randomised controlled trial.
    BMC Cancer. 2017;17:106.
    PubMed     Text format     Abstract available

  13. IRELAND MJ, March S, Crawford-Williams F, Cassimatis M, et al
    A systematic review of geographical differences in management and outcomes for colorectal cancer in Australia.
    BMC Cancer. 2017;17:95.
    PubMed     Text format     Abstract available

  14. RIGTER LS, Spaander MC, Moons LM, Bisseling TM, et al
    Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: study design.
    BMC Cancer. 2017;17:112.
    PubMed     Text format     Abstract available

    BMC Gastroenterol

  15. LUNDGREN D, Rutegard J, Eklof V, Palmqvist R, et al
    Patients with longstanding ulcerative colitis in remission do not have more irritable bowel syndrome-like symptoms than controls.
    BMC Gastroenterol. 2016;16:139.
    PubMed     Text format     Abstract available


  16. REDDY SK, Boland PM, Nurkin SJ
    Primary tumor resection does not improve survival among patients with unresectable colorectal cancer metastases-But who determines resectability?
    Cancer. 2017 Feb 8. doi: 10.1002/cncr.30595.
    PubMed     Text format    

    Cancer Lett

  17. PAN Q, Meng L, Ye J, Wei X, et al
    Transcriptional repression of miR-200 family members by Nanog in colon cancer cells induces epithelial-mesenchymal transition (EMT).
    Cancer Lett. 2017 Feb 2. pii: S0304-3835(17)30081.
    PubMed     Text format     Abstract available

    Clin Cancer Res

  18. WENG W, Wei Q, Toden S, Yoshida K, et al
    Circular RNA ciRS-7 - A promising prognostic biomarker and a potential therapeutic target in colorectal cancer.
    Clin Cancer Res. 2017 Feb 7. pii: clincanres.2541.2016.
    PubMed     Text format     Abstract available

    Gastrointest Endosc

  19. GUIVATCHIAN T, Koeppe ES, Baker JR, Moisa C, et al
    Family History in Colonoscopy Patients: Feasibility and Performance of Electronic and Paper-based Surveys for Colorectal Cancer Risk Assessment in the Outpatient Setting.
    Gastrointest Endosc. 2017 Feb 4. pii: S0016-5107(17)30080.
    PubMed     Text format     Abstract available


  20. YAZICI C, Wolf PG, Kim H, Cross TL, et al
    Race-dependent association of sulfidogenic bacteria with colorectal cancer.
    Gut. 2017 Feb 2. pii: gutjnl-2016-313321. doi: 10.1136/gutjnl-2016-313321.
    PubMed     Text format     Abstract available

    Int J Colorectal Dis

  21. SUN F, Chen L, Shi M, Yang X, et al
    Prognosis of video-assisted thoracoscopic pulmonary metastasectomy in patients with colorectal cancer lung metastases: an analysis of 154 cases.
    Int J Colorectal Dis. 2017 Feb 7. doi: 10.1007/s00384-017-2768.
    PubMed     Text format     Abstract available

    J Clin Oncol

  22. SEPULVEDA AR, Hamilton SR, Allegra CJ, Grody W, et al
    Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology.
    J Clin Oncol. 2017 Feb 6:JCO2016719807. doi: 10.1200/JCO.2016.71.9807.
    PubMed     Text format     Abstract available

    J Surg Oncol

  23. SASAKI K, Andreatos N, Margonis GA, He J, et al
    The prognostic implications of primary colorectal tumor location on recurrence and overall survival in patients undergoing resection for colorectal liver metastasis.
    J Surg Oncol. 2016;114:803-809.
    PubMed     Text format     Abstract available

  24. KOSTNER AH, Kersten C, Lowenmark T, Ydsten KA, et al
    The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker.
    J Surg Oncol. 2016;114:895-899.
    PubMed     Text format     Abstract available


  25. SAITO G, Sadahiro S, Kamata H, Miyakita H, et al
    Monitoring of Serum Carcinoembryonic Antigen Levels after Curative Resection of Colon Cancer: Cutoff Values Determined according to Preoperative Levels Enhance the Diagnostic Accuracy for Recurrence.
    Oncology. 2017 Feb 9. doi: 10.1159/000456075.
    PubMed     Text format     Abstract available

    PLoS One

  26. KINAR Y, Akiva P, Choman E, Kariv R, et al
    Performance analysis of a machine learning flagging system used to identify a group of individuals at a high risk for colorectal cancer.
    PLoS One. 2017;12:e0171759.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.